三友醫療(688085.SH):Zeus脊柱系統是公司最新一代脊柱高端釘棒矯形系統產品
格隆匯10月18日丨有投資者在投資者互動平台向三友醫療(688085.SH)提問,“公司Zeus 脊柱系統產品獲得美國認證,想了解此產品的相關情況。請問此產品是新研發的創新產品?還是國內相似產品線推廣在美國的認證和市場開拓?”
公司表示,Zeus脊柱系統是公司最新一代脊柱高端釘棒矯形系統產品,該產品是公司最新研製開發的一整套能解決從椎體骨折、退變、畸形、兒童術式等一系列適應證,應用領域可以實現融合、滑脱、骨折、複雜脊柱矯形,開放和微創等全覆蓋的胸腰椎後路釘棒系統。公司以全球首創模塊化內固定產品為基礎,結合相關產品上市多年來的客户體驗與反饋,根據臨牀提出的進一步手術需求,進行了植入物優化和配套工具全新設計和研製開發,代表目前公司最完整胸腰椎手術先進設計理念。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.